American Century entities reported beneficial ownership stakes in DXC Technology Company Common Stock. The filing lists holdings as of 03/31/2026, showing American Century ETF Trust with 8,706,339 shares (5.1%) and American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research each with 9,074,619 shares (5.4%). The schedule identifies voting and dispositive power as sole for those holdings and states the filings were signed on 05/01/2026.
Positive
None.
Negative
None.
Insights
Filing documents passive large-shareholder positions with sole voting and dispositive power.
The schedule catalogs beneficial ownership by related American Century entities and Stowers Institute, listing exact share counts and percentages tied to Common Stock CUSIP 23355L106. The positions are characterized with sole voting and sole dispositive power in the cover entries.
Disclosure aligns with Schedule 13G reporting for large, passive investors; subsequent filings may update positions if holdings change. The signing dates and the explicit share counts provide clear, auditable ownership snapshots for governance records.
Key Figures
American Century ETF Trust holdings:8,706,339 sharesACIM holdings:9,074,619 sharesACCI/ Stowers holdings (each):9,074,619 shares+1 more
4 metrics
American Century ETF Trust holdings8,706,339 sharesCommon Stock, <date>03/31/2026</date>
Percent of class (example)5.1% and 5.4%Reported percent of class for listed holders
Key Terms
Schedule 13G, Beneficially owned, Sole dispositive power, CUSIP
4 terms
Schedule 13Gregulatory
"Item 1. | (a) | Name of issuer: DXC Technology Company"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole dispositive powerfinancial
"5 | Sole Dispositive Power 8,706,339.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
CUSIPtechnical
"Item 2. | (e) | CUSIP Number(s): 23355L106"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
DXC Technology Company
(Name of Issuer)
Common Stock
(Title of Class of Securities)
23355L106
(CUSIP Number)
03/31/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
23355L106
1
Names of Reporting Persons
American Century ETF Trust
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
8,706,339.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
8,706,339.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,706,339.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.1 %
12
Type of Reporting Person (See Instructions)
IV
SCHEDULE 13G
CUSIP Number(s):
23355L106
1
Names of Reporting Persons
American Century Investment Management, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
9,074,619.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
9,074,619.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,074,619.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.4 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
23355L106
1
Names of Reporting Persons
American Century Companies, Inc.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
9,074,619.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
9,074,619.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,074,619.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.4 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
CUSIP Number(s):
23355L106
1
Names of Reporting Persons
Stowers Institute for Medical Research
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
9,074,619.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
9,074,619.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
9,074,619.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.4 %
12
Type of Reporting Person (See Instructions)
HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
DXC Technology Company
(b)
Address of issuer's principal executive offices:
20408 Bashan Drive, Suite 231, Ashburn, Virginia, 20147
Item 2.
(a)
Name of person filing:
American Century ETF Trust
American Century Investment Management, Inc.
American Century Companies, Inc.
Stowers Institute for Medical Research
(b)
Address or principal business office or, if none, residence:
4500 Main Street
9th Floor
Kansas City, Missouri 64111
(c)
Citizenship:
Delaware
(d)
Title of class of securities:
Common Stock
(e)
CUSIP Number(s):
23355L106
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See the response(s) to Item 9 on the attached cover page(s).
(b)
Percent of class:
See the response(s) to Item 11 on the attached cover page(s).
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See the response(s) to Item 5 on the attached cover page(s).
(ii) Shared power to vote or to direct the vote:
See the response(s) to Item 6 on the attached cover page(s).
(iii) Sole power to dispose or to direct the disposition of:
See the response(s) to Item 7 on the attached cover page(s).
(iv) Shared power to dispose or to direct the disposition of:
See the response(s) to Item 8 on the attached cover page(s).
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Various persons, including the investment companies and separate institutional investor accounts that American Century Investment Management, Inc. ("ACIM") serves as investment adviser, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities that are the subject of this schedule. Except as may be otherwise indicated if this is a joint filing, not more than 5% of the class of securities that is the subject of this schedule is owned by any one client advised by ACIM.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
This Item identifies each subsidiary of American Century Companies, Inc. ("ACC"), which is controlled by the Stowers Institute for Medical Research, that is a beneficial owner of securities that are subject of this schedule (the "Subject Securities"). American Century Investment Management, Inc. ("ACIM") is a wholly-owned subsidiary of ACC and an investment adviser registered under Section 203 of the Investment Advisers Act of 1940.
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(K), so indicate under Item 3(k) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
Not applicable
Item 9.
Notice of Dissolution of Group.
Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5.
Not applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
American Century ETF Trust
Signature:
American Century ETF Trust
Name/Title:
/s/ John Pak / Senior Vice President
Date:
05/01/2026
American Century Investment Management, Inc.
Signature:
American Century Investment Management, Inc.
Name/Title:
/s/ John Pak / Senior Vice President
Date:
05/01/2026
American Century Companies, Inc.
Signature:
American Century Companies, Inc.
Name/Title:
/s/ John Pak / Senior Vice President
Date:
05/01/2026
Stowers Institute for Medical Research
Signature:
Stowers Institute for Medical Research
Name/Title:
/s/ Joselyn Verschelden / Authorized Signer
Date:
05/01/2026
Exhibit Information
EXHIBIT
Each of the undersigned hereby agrees and consents to the execution and joint filing on its behalf by American Century Investment Management, Inc. of this Schedule 13G respecting the beneficial ownership of the securities which are the subject of this schedule.
Dated this 1st day of May, 2026.
AMERICAN CENTURY ETF TRUST ("ACETF")
AMERICAN CENTURY INVESTMENT MANAGEMENT, INC. ("ACIM")
AMERICAN CENTURY COMPANIES, INC. ("ACC")
By: __/s/ John Pak__________________
John Pak
Senior Vice President, ACETF, ACIM and ACC
STOWERS INSTITUTE FOR MEDICAL RESEARCH, solely in its capacity as control entity of ACC
By: __/s/ Joselyn Verschelden_________
Joselyn Verschelden
Authorized Signer
What stake did American Century report in DXC (DXC)?
American Century entities reported stakes of 8,706,339 and 9,074,619 shares. The cover lists American Century ETF Trust at 8,706,339 shares (5.1%) and ACIM/ACC at 9,074,619 shares (5.4%), tied to CUSIP 23355L106 as of 03/31/2026.
Does the Schedule 13G filing state voting power for the DXC shares?
Yes. The filing shows sole voting and sole dispositive power for the listed holdings. Each cover entry reports sole voting power and sole dispositive power equal to the stated share counts for the reporting entities.
Who signed the DXC beneficial ownership filing?
The filing was signed by John Pak and Joselyn Verschelden on behalf of the reporting entities. John Pak signed for American Century ETF Trust, ACIM and ACC; Joselyn Verschelden signed for Stowers Institute, with signature dates shown as 05/01/2026.
What date does the DXC ownership snapshot reference?
The cover shows 03/31/2026 as the reference date for the share counts. The signature block lists execution on 05/01/2026, indicating the reporting period and the date the schedule was signed for filing.
Is the ownership reported on behalf of clients by American Century advisors?
The filing states ACIM serves as investment adviser to various clients who may have rights to dividends or sale proceeds. It notes that multiple client accounts advised by ACIM may be the ultimate recipients, and that no single client advised by ACIM owns more than 5% in the joint-filing context.
